摘要
Abstract
Objective To explore and analyze the clinical efficacy of Novomix30 and pre-mixed30R in the treatment of type 2 diabetes mellitus (T2DM). Methods 60 cases with T2DM in our hospital from May 2010 to September 2012 were selected and retrospectively analyzed,the patients were divided into Novomix30 group and pre-mixed30R group according to the treatment they received,each group had 30 cases, the two groups were treated by Novomix30 and pre-mixed30R respectively.Observed and compared the efficacy of the two groups after a period of treatment. Results compared with before the treatment, FPG,HbA1C and 2hPBG of the two groups had both decreased significantly,but HbA1C and 2hPBG in Novomix30 group decreased more significantly(P<0.01;P<0.05),hypoglycemia probability in Novomix30 group was lower than that in pre-mixed30R group(P < 0.05). Conclusion Novomix30 and pre-mixed30R both can reduce glycemic index,but compare with pre-mixed30R,Novomix30 in blood sugar levels and hypoglycemia reaction for type 2 diabetic patients have a more prominent superiority.关键词
诺和锐30/诺和灵30R/2型糖尿病Key words
Novomix30/Pre-mixed30R/Type 2 diabetes分类
医药卫生
